NEW YORK (GenomeWeb News) – Sigma-Aldrich today reported its third-quarter sales grew 2 percent year over year on soft demand from its research end markets and a 6 percent negative effect from foreign currency exchange.

The St. Louis-based chemicals and research products firm reported total sales of $639 million for the three months ended Sept. 30 compared to $626 million in sales for the third quarter of 2011. It fell short of Wall Street's consensus estimate of $657.6 million.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Science speaks with the University of Michigan's Jedidiah Carlson, who has tracked population genetic discussions at white nationalist sites.

Gene therapies could qualify for a faster US Food and Drug Administration approval process, according to Stat News.

NPR reports that the US House of Representatives has passed a bill to enable terminally ill patients access to experimental drugs.

In Genome Research this week: inversion variants mapped in human, non-human primate genomes; transcriptome profiling of maize, sorghum; and more.